ISCHEMIA Trial Validates 'Slow Medicine'
]]>(MedPage Today) -- The recent release of findings from the ISCHEMIA trial has sent shockwaves through the cardiology community, suggesting that one of the most common and lucrative procedures in the field – coronary revascularization for...
Read more »